Indian Journal of Urology Users online:1464  
Home Current Issue Ahead of print Editorial Board Archives Symposia Guidelines Subscriptions Login 
Print this page  Email this page Small font sizeDefault font sizeIncrease font size
Year : 2011  |  Volume : 27  |  Issue : 2  |  Page : 262-268

Role of systemic peri-operative chemotherapy in management of transitional cell carcinoma of bladder

1 Department of Urology, Dr RML Hospital and PGIMER, New Delhi, India
2 Academic & Research, Medanta Institute of Kidney and Urology, Medanta - The Medicity, Gurgaon, Formerly Professor and Head, Department of Urology All India Institute of Medical Sciences, New Delhi, India

Correspondence Address:
Narmada P Gupta
Academic & Research,Urology, Medanta Institute of Kidney and Urology Medanta - The Medicity, Gurgaon, Delhi NCR
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/0970-1591.82847

Rights and Permissions

Bladder cancer has variable biological behavior pattern in different individuals and the debate regarding peri-operative use of systemic chemotherapy with the surgical management remains. The optimal treatment strategy, regimen and the timing of peri-operative chemotherapy are not yet known. Here we review the existing literature for the use of systemic peri-operative chemotherapy in management of advanced bladder cancer.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded267    
    Comments [Add]    

Recommend this journal